Probability of downsizing primary tumors of renal cell carcinoma by targeted therapies is related to size at presentation.
Kroon, Bin K
Probability of downsizing primary tumors of renal cell carcinoma by targeted therapies is related to size at presentation. [electronic resource] - Urology Jan 2013 - 111-5 p. digital
Publication Type: Journal Article; Review
1527-9995
10.1016/j.urology.2012.09.014 doi
Carcinoma, Renal Cell--drug therapy
Humans
Indoles--therapeutic use
Kidney Neoplasms--drug therapy
Neoadjuvant Therapy
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Probability
Protein Kinase Inhibitors--therapeutic use
Pyrroles--therapeutic use
Sorafenib
Sunitinib
Tumor Burden--drug effects
Probability of downsizing primary tumors of renal cell carcinoma by targeted therapies is related to size at presentation. [electronic resource] - Urology Jan 2013 - 111-5 p. digital
Publication Type: Journal Article; Review
1527-9995
10.1016/j.urology.2012.09.014 doi
Carcinoma, Renal Cell--drug therapy
Humans
Indoles--therapeutic use
Kidney Neoplasms--drug therapy
Neoadjuvant Therapy
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Probability
Protein Kinase Inhibitors--therapeutic use
Pyrroles--therapeutic use
Sorafenib
Sunitinib
Tumor Burden--drug effects